CIK 0001626878 · Non-accelerated filer<br>Smaller reporting company
XBiotech Inc.
Sign in to watch- Ticker
- XBIT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 512-386-2900
- Business address
- 5217 WINNEBAGO LANE, AUSTIN, TX, 78744
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Executive Officer acquired 500,000 shares (option exercise)
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale 10% owner sold 1,173,033 shares at $18.78 ($22,029,560)
- 4 Open-market sale 10% owner sold 182,836 shares at $18.42 ($3,367,839)
- 4 Open-market sale Director sold 375,000 shares at $18.30 ($6,862,500)
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Other disposition Chief Executive Officer disposed of 500,000 shares (other)
- 4 Open-market sale Chief Scientific Officer sold 40,000 shares at an average $20.00 ($800,193)
- 4 Option exercise VP Finance & HR acquired 57,692 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP Finance & HR sold 51,841 shares at $19.65 ($1,018,899)
- 4 Open-market sale VP Finance & HR sold 1,300 shares at $19.30 ($25,090)
Page 7 of 21 · 408 filings